Navigation Links
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
Date:6/8/2012

not significant)
  • 1 mg: 57 percent (p<0.05)
  • Placebo: 41 percent
  • ACR50

    • 8 mg: 40 percent (p<0.001)
    • 4 mg: 35 percent (p<0.001)
    • 2 mg: 17 percent (not significant)
    • 1 mg: 31 percent (p<0.05)
    • Placebo: 10 percent

    ACR70

    • 8 mg: 20 percent (p<0.001)
    • 4 mg: 23 percent (p<0.001)
    • 2 mg: 8 percent (not significant)
    • 1 mg: 12 percent (p<0.05)
    • Placebo: 2 percent

    Safety Results

    The most common treatment-emergent adverse event class was infections, with a similar rate observed among patients in the placebo group (12 percent) and patients receiving baricitinib (14 percent). One patient in the placebo group was diagnosed with an opportunistic infection of toxocariasis. No deaths or opportunistic infections occurred in the active treatment groups.

    There were seven serious adverse events reported in six patients (two events in the placebo group, four in the 2 mg group and one in the 8 mg group). Dose-dependent changes in laboratory tests (hemoglobin, neutrophil, serum creatinine, LDL and HDL) were observed, with greater changes being observed in the 8 mg baricitinib group. 

    A copy of the EULAR oral presentation can be accessed at:  Link to Presentation.

    Trial Design and Status

    This Phase IIb trial consists of three parts: Part A, Part B and an open-label extension. Part A was randomized, double-blind and placebo-controlled. Patients randomized to baricitinib received one of four doses administered once daily for 12 weeks.

    In Part B, patients initially randomized to placebo or the 1 mg baricitinib dose were re-randomized to receive either 4 mg once da
    '/>"/>

    SOURCE Eli Lilly and Company; Incyte Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
    2. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
    3. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
    4. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
    5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    6. DiversityInc Names Lilly a Top Company for Diversity
    7. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
    8. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
    9. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
    10. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
    11. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... 2014  Decision Resources Group is launching an extension ... to now include ChinaTrack; the new capabilities track the ... interactive dashboard providing detailed brand-level share tracking and analytics. ... level. Other key capabilities of the new ... addition to end-user surveys of healthcare facilities, ChinaTrack data ...
    (Date:7/31/2014)... -- Touro University California,s College of Pharmacy is pleased ... of a $150,000 grant by the Joseph & Vera ... research and classroom space on its campus. ... of health sciences, and will help us apply high-tech ... our students," said Shelley Berkley , CEO and ...
    (Date:7/31/2014)... Hovione today announced that its API plant in ... pre-approval inspection by the US Food and Drug Administration (FDA). ... Safety Officer, Ms. Britanny Terhar , lasted 5 days ... concluded on the 25 th . The inspection confirmed the ... Good Manufacturing Practices (GMP) and no Form 483 observations were ...
    Breaking Medicine Technology:Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Touro University California Garners Grant From Long Foundation 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2
    (Date:7/31/2014)... August 01, 2014 The 2013 ... increasing 0.89 points from 75.07 in 2012. The ... tourism-related sectors and integrates them into an overall ... become increasingly more satisfied with Hong Kong over ... consistently excelling in service performance in Hong Kong ...
    (Date:7/31/2014)... Ce-Classes.com has announced that they are ... professionals, a Systematic Review of Sexual Satisfaction . ... the International Journal of Clinical and Health Psychology. , ... a need to have accurate information about sexual satisfaction ... possible. The material provides a systematic review of ...
    (Date:7/31/2014)... In today’s world, a good night’s sleep has become ... apnea (a medical problem where the airway collapses during sleep ... the rest they need to face their daily challenges. ... million people in the United States alone have sleep apnea. ... of those treated, many cannot tolerate their prescribed medical device ...
    (Date:7/31/2014)... Weblify has finally been released by marketing and advertising ... The result is a perfected and fine tuned platform ... minutes without knowing any HTML or other programming languages. , ... SEO expert, agrees that this platform allows anyone to create ... web site builders out there, but this is truly unique. ...
    (Date:7/31/2014)... Cosmetic Town is a new web ... consumers considering cosmetic treatments. The site features doctors ... is to educate prospective patients on a variety of ... validated referral system that helps patients find cosmetic specialists ... respective fields. , Cosmetic Town started its recruitment ...
    Breaking Medicine News(10 mins):Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2
    ... 60-year-old drug chloroquine eliminated certain malignancies in mice, researchers ... common anti-malaria drug called chloroquine can also prevent the ... a U.S. study finds. , The finding may help ... , Scientists at The Scripps Institute and St. Jude,s ...
    ... to protect the heart, can lead to halting of ... News) -- Men undergoing hormone therapy for prostate cancer ... a significantly higher risk of dying, new research suggests. ... to elevate liver-function test levels. The end result is ...
    ... Therapy that stimulates the hand muscles may help treat ... causes muscles spasms in musicians, according to a study ... Neurology, the medical journal of the American Academy of ... practiced particular complicated movements for years. The muscle spasms ...
    ... Inc. (Nasdaq: GTIV ), the nation,s leading provider ... it is,scheduled to present from 1:30 p.m. to 2:00 ... JPMorgan Healthcare Conference in San Francisco., The event ... audio web cast,which may be accessed by visiting ...
    ... Medical,Affiliates, Inc. (OTC Bulletin Board: UCIA) reported that revenue ... from $63,672,000 for,the year ended September 30, 2006, an ... September 30, 2007 was $17,885,000 or 9%,greater than the ... increase in revenues is attributed to the opening of ...
    ... taken more seriously , , WEDNESDAY, Dec. 26 (HealthDay News) ... person,s risk of having a stroke or developing dementia, ... to previous research linking "mini-strokes" to full-fledged strokes, make ... neurology at Johns Hopkins University School of Medicine. , ...
    Cached Medicine News:Health News:Malaria Drug Promising Against Cancer 2Health News:Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients 2Health News:Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients 3Health News:Stimulating muscles may improve musician's dystonia 2Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 2Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 3Health News:UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007 2Health News:UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007 3Health News:Temporary Amnesia, Confusion Raise Stroke, Dementia Risk 2Health News:Temporary Amnesia, Confusion Raise Stroke, Dementia Risk 3
    ... to 10 inches/ 25 cm thinner than other benchtop ... X-22 Series is the space-saving multipurpose solution for your ... 46 cm wide • 11 Rotor Library • Achieve ... to Spin 1.5 mL & PCR+ Tubes: 24-place ...
    ... purpose centrifuges offer high-volume versatility along with ... making them ideal for a wide variety ... Four- or six-place sealed swinging bucket ... rotors offered , Lare capacity (4 x ...
    ... designed to accommodate over 55 centrifuge tubes, ... heat labile samples. Incorporating the latest technology, ... automatic quick cooling from 22 C to ... maintenance brushless motor, low pitch 62 dBA ...
    Inquire...
    Medicine Products: